Source: Eur Respir Rev, 30 (162) 210161; 10.1183/16000617.0161-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Frédéric Perros, Marc Humbert, Peter Dorfmüller. Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension. Eur Respir Rev, 30 (162) 210161; 10.1183/16000617.0161-2021

Member's Comments

No comment yet.

Related content which might interest you: Inflammation in pulmonary arterial hypertension: is it time to quell the fire? Source: Eur Respir J 2014; 43: 685-688 Year: 2014 Pulmonary arterial hypertension and the Enigma code of smouldering inflammation Source: Eur Respir J 2016; 48: 305-307 Year: 2016 Is there an obesity paradox in pulmonary arterial hypertension? Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 The obesity paradox in pulmonary arterial hypertension: the Scottish perspective Source: ERJ Open Res, 5 (4) 00241-2019; 10.1183/23120541.00241-2019 Year: 2019 Pulmonary arterial hypertension: an autoimmune disease? Source: Eur Respir J 2005; 26: 986-988 Year: 2005 Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 How does inflammation contribute to pulmonary hypertension? Source: Eur Respir J, 51 (1) 1702403; 10.1183/13993003.02403-2017 Year: 2018 Challenging the concept of adding more drugs in pulmonary arterial hypertension Source: Eur Respir J, 50 (3) 1701527; 10.1183/13993003.01527-2017 Year: 2017 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Inflammation in chronic thromboembolic pulmonary hypertension: accomplice or bystander in altered angiogenesis? Source: Eur Respir J 2015; 46: 303-306 Year: 2015 The revolution of pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 361-363 Year: 2016 The new definition of pulmonary hypertension Source: Eur Respir J 2009; 34: 790-791 Year: 2009 Microvascular disease in chronic thromboembolic pulmonary hypertension: the story continues Source: Eur Respir J 2014; 44: 1121-1122 Year: 2014 Chronic thromboembolic pulmonary hypertension: do we need a new definition? Source: Eur Respir J 2014; 44: 1401-1403 Year: 2014 Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer? Source: Eur Respir J 2009; 33: 1247-1249 Year: 2009 Treat-to-target approach in pulmonary arterial hypertension: a consensus-based proposal Source: Eur Respir Rev 2012 21:259-262 Year: 2012 Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension Source: Eur Respir J , 49 (2) 1601897; DOI: 10.1183/13993003.01897-2016 Year: 2017 Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Chronic thromboembolic pulmonary hypertension: role of medical therapy Source: Eur Respir J 2013; 41: 985-990 Year: 2013 Pulmonary arterial hypertension and the state of limbo Source: Eur Respir Rev 2010 19: 264-265 Year: 2010